Illumina ILMN and Partners HealthCare today announced a
strategic alliance to offer medical geneticists and pathologists
infrastructure and networking tools to support the interpretation and
reporting process for genetic sequencing data. The tools will integrate the
functionality of Illumina's MiSeq® sequencing system and Partners GeneInsight
Suite®, an IT platform that streamlines the analysis, interpretation, and
reporting of complex genetic test results. The GeneInsight Suite is registered
with the FDA as a Class I exempt medical device.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in